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ABSTRACT
Rapid advance in sequencing technology has led to genome-wide analysis of genetic and
epigenetic features simultaneously, making it possible to understand the biological mechanisms
underlying cancer initiation and progression. However, how to identify important prognostic
features poses a great challenge for both statistical modeling and computing. In this thesis, a
network-based approach is applied to the Cancer Genome Atlas (TCGA) ovarian cancer data to
identify important genes related to the overall survival of ovarian cancer patients. In the first
step, a stepwise correlation-based selector is used to reduce the dimensionality of TCGA data, by
filtering out a large number of unrelated genes. Second, we employ the graphical lasso to
construct a sparse gene-gene co-expression network. The undirected network allows us to
classify genes into groups based on gene-gene interaction. We fit a cox proportional hazard
model with a sparse group lasso penalty for further variable selection and identify 232 genes,
which are prognostic for ovarian cancer survival. Of these 232 genes, many were reported to be
associated with cancer initiation or progression in the literature. The Kaplan-Meier curves based
on the identified genes show clear separation among different groups of patients based on
different gene expression levels.
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1. INTRODUCTION
Ovarian cancer is one of the most common gynecologic cancers, ranking fifth as the
cause for cancer-related deaths among women in the United States. According to The American
Cancer Society, it is estimated that about 22, 280 women will receive a new diagnosis of ovarian
cancer and about 14, 240 women will die from it in 2016. About 70% of most deaths occur in
patients with advanced-stage, high-grade serous ovarian cancer.
The standard treatment for these patients is usually surgery, followed by platinum-taxane
chemotherapy. Platinum-resistant cancer often recurs within six months in about 25% of patients
and there is an overall five-year survival probability of 31%. Approximately 13% of high-grade
serous ovarian cancer can be attributed to germline mutations in BRCA1 and BRCA2 and a
smaller percentage can be accounted for by other germline mutations (The Cancer Genome Atlas
Research Network [8]).
Due to the rapid advances in next-generation sequencing technology, it is now possible to
simultaneougly perform genome-wide analysis of genetic and epigenetic features (Zhang et al.
[47]). The Cancer Genome Atlas (TCGA) project provides the most extensive genomic data
resource for more than 30 types of cancers (http://cancergenome.nih.gov/). For instance, the
ovarian cancer data from the TCGA contain both clinical and molecular profiles from 586 tumor
samples. The clinical profile includes records on recurrence, survival, and treatment resistance.
The molecular profile includes copy number variation (CNV), DNA methylation, exon
expression, gene expression (microarray), gene expression (RNA-seq), genotype (SNP),
MicroRNA expression (microarray), MicroRNA-seq, protein expression, and somatic mutation.
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These high-dimensionality datasets have motivated the study of molecular mechanisms of cancer
through computational approaches.
A crucial step in the construction of a regression model when there are tens of
thousands of features present in the dataset is feature selection. The purpose of feature selection
is to select a subset of the original features so that the feature space is optimally reduced based
on a certain evaluation criterion. As the years progress, the dimensionality of data keeps
increasing in both the number of instances as well as the number of features in various
applications. This high-dimensionality leads to problems such as scalability and learning
performance of many machine learning algorithms. For instance, high-dimensional data such as a
gene expression dataset with hundreds or thousands of genes can have large amount of irrelevant
and redundant features which may significantly reduce the performance of machine learning
algorithms. Through feature selection, we are able to remove irrelevant or redundant features
which increases computational efficiency and estimation accuracy.
Feature selection algorithms are divided into two categories which include the filter
model and the wrapper model. Using the filter model, certain features are selected based on
general characteristics of the training data without the use of any learning algorithm. On the
other hand, the wrapper model uses the performance of a predetermined learning algorithm to
evaluate and select the features. The wrapper model has a superior learning performance than the
filter model since it selects features which are more suited to the predetermined learning
algorithm; however, it tends to be more computationally expensive than the filer model. So, the
filter model is often preferred due to its computational efficiency when dealing with a large
number of features.
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Zhang et al. [49] proposed a novel stepwise correlation-based selector (SCBS) which
imitates the hierarchy of the Bayesian network model for feature selection. This approach was
applied to the TCGA ovarian cancer data and several interesting results were obtained which
provided insight on the genetic/epigenetic mechanisms of ovarian cancer.
In this paper, we identify biomarkers which play a crucial role in the overall survival of
the ovarian cancer patients. The data we are going to analyze is the ovarian cancer data, which
was retrieved from the TCGA portal. The ovarian cancer data from TCGA includes 586 samples
with gene expression profiles containing level 3 UNC Agilent G4502A_07 microarrays. The data
contains gene expression level for 17,814 genes. Due to the high-dimensionality of the data, we
use the stepwise correlation-based selector (SCBS) proposed by Zhang et al. [49] and select a
subset of 603 genes from the 17, 814 genes. With these 603 genes, we will construct an
undirected network using the graphical lasso model proposed by Friedman et al. [11]. This will
allow for the identification of gene clusters, which will be used in fitting a cox proportional
hazard model using a sparse group lasso penalty (Friedman et al. [12]).
The rest of paper is organized as follows: in Chapter 2, we provide some background
information through the revision of papers based on the sparse inverse covariance estimation
with the graphical lasso and sparse group lasso. In Chapter 3, we study statistical methods such
as the stepwise correlation-based selector, graphical lasso, cox proportional hazard model with
sparse group lasso penalty, and Kaplan-Meier curves. In Chapter 4, we interpret the results
obtained from the analysis. Conclusions are given in Chapter 5.
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2. BACKGROUND/LITERATURE REVIEW

2.1 Sparse inverse covariance estimation with the graphical lasso
Several authors have proposed the method of 𝑙1 (lasso) regularization as a form of
estimating sparse undirected graphical models. The underlying assumption for this basic model
is that the observations follow a multivariate Gaussian distribution with mean 𝜇 and covariance
matrix Σ. Given other variables, variables 𝑖 and 𝑗 are said to be conditionally independent if the
𝑖𝑗 𝑡ℎ component of Σ −1 is zero. For this reason, an 𝑙1 penalty is imposed when estimating Σ −1
under sparsity assumption.
Different methods for the optimization of the exact log-likelihood have been proposed by
several researchers (Yuan and Lin [46]; Banerjee et al. [3]; Friedman et al. [11]). Given 𝑛
multivariate normal observations of dimension 𝑝, with mean 𝜇 and covariance matrix Σ, we want
to maximize the penalized log-likelihood

l(Θ) = log |Θ| − 𝑡𝑟(𝑆Θ) − 𝜆‖Θ‖1

( 2.1.1)

where 𝑆 represents the sample covariance matrix, Θ = Σ −1, and ‖Θ‖1 = ∑𝑖,𝑗 |Θij |.
According to Banerjee et al. [3], the maximization of equation (2.1.1) is equivalent to
solving the dual problem
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1
1
1
−
2
min { ‖𝑊11
𝛽 − 𝑊112 𝑠12 ‖ + 𝜆‖𝛽‖1 }
𝛽
2
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( 2.1.2)

where
𝑊11
𝑇
𝑤12

𝑤12
]
𝑤22

( 2.1.3)

𝑆11
𝑇
𝑠12

𝑠12
]
𝑠22

( 2.1.4)

𝑊=[
𝑆=[

−1
Suppose we let 𝛽 = 𝑊11
𝑤12, then the problem becomes much easier due to the

equivalence between (2.1.1) and (2.1.2). This lasso problem can be solved using a coordinate
descent procedure. Friedman et al. [13] developed a simple algorithm known as the graphical
lasso, which is extremely fast. This algorithm is able to solve a 1000-node problem within a
minute and is 3000 times faster than other competing algorithms. The graphical lasso algorithm
can be implemented as follows:
Step 1
Compute 𝑊 = 𝑆 + 𝜆𝐼

Step 2
Solve the lasso problem in (2.1.2) and estimate 𝛽. Replace 𝑤12 = 𝑊11 𝛽.

Step 3

Continue until 𝑊 converges.
Since the graphical lasso algorithm is simple and fast in estimating a sparse inverse
covariance matrix using the 𝑙1 penalty, it should aid in the application of sparse inverse
covariance procedures involving large datasets, which contain thousands of parameters.
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2.2 A sparse-group lasso
For problems where there are grouped covariates, which can have sparse effects on a
group as well as within group level, a regularized model for linear regression is introduced with
𝑙1 and 𝑙2 penalties. Let us begin by examining the usual linear regression model. We have a
dataset which consists of an 𝑛 response vector 𝑦, and an 𝑛 by 𝑝 matrix of features, 𝑋. In recent
times, we have been presented with applications in which 𝑝 ≫ 𝑛. For such applications, standard
regression fails. To overcome this problem, Tibshirani [41] developed the lasso approach, which
regularizes the problem by bounding the 𝑙1 norm of the solution. The lasso approach minimizes

1
‖𝑦 − 𝑋𝛽‖2 + 𝜆‖𝛽‖1
2

( 2.2.1)

and computes a solution with a small number of nonzero entries in 𝛽. Suppose our data contains
predictor variables which are divided into 𝑚 different groups. An example of this is gene
expression data which may contain groups for gene pathways or factor level indicators in
categorical data.
The objective is to find a solution which uses only a few of the groups, in addition to
achieving sparsity in 𝛽. To solve this problem, Yuan and Lin [46] proposed the group lasso
criterion. The problem is as follows

2

𝑚

𝑚

1
min ‖𝑦 − ∑ 𝑋 (𝑙) 𝛽 (𝑙) ‖ + 𝜆 ∑ √𝑝𝑙 ‖𝛽 (𝑙) ‖
𝛽 2
𝑙=1

𝑙=1
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( 2.2.2)

where 𝑋 (𝑙) is a submatrix of 𝑋 with columns corresponding to the predictors in group 𝑙, 𝛽 (𝑙) is
the coefficient vector corresponding to that group and 𝑝𝑙 is the length of 𝛽 (𝑙) . The magnitude of
the tuning parameter 𝜆 determines the sparsity of the solution. Note that if each group size is 1,
the result is a regular lasso solution.
The group lasso model yields a sparse set of groups; however, the presence of a group in
the model results in all nonzero coefficients in the group. Suppose we want to achieve both
sparsity of groups and within each group. To do this, we use the sparse group lasso, which uses
the formula

𝑚

2

𝑚

1
min ‖𝑦 − ∑ 𝑋 (𝑙) 𝛽 (𝑙) ‖ + (1 − 𝛼)𝜆 ∑ √𝑝𝑙 ‖𝛽 (𝑙) ‖ + 𝛼 𝜆‖𝛽‖1
𝛽 2𝑛
𝑙=1

( 2.2.1)

𝑙=1

where 𝛼 ∈ [0,1]. The mixing parameter, 𝛼, is a convex combination of the lasso and group lasso
penalties since 𝛼 = 0 produces a group lasso fit and 𝛼 = 1 produces a lasso fit.
The sparse group lasso model is often used for regression problems involving categorical
predictors. For predictors with a large number of levels, many of the levels for the predictors
included are sometimes not very informative so the sparse group lasso accounts for this by
replacing the coefficients with zero for many levels even in the nonzero groups. The sparse
group lasso is sometimes useful for analyzing gene expression data as it is able to find interesting
pathways from which driving genes are selected. In addition, the model also reduces the
estimated effects of driving genes within a group toward one another (Simon et al. [34]).
For comparison purposes, all three models (sparse group lasso, group lasso, and lasso)
were applied on two real data examples involving gene expression data, the colitis data and
7

breast cancer data. In the colitis data, the lasso outperformed the group lasso and the sparse
group lasso while in the breast cancer data, the sparse group lasso outperformed the lasso and
group lasso. The difference in these results is due to the fact that group information in the cancer
data is critical for classification and the grouping provides us with insights into the biological
mechanisms while the group information in the colitis data simply increases model variance.
Although the sparse group lasso may not be applicable to all grouped data, it can sometimes be
useful as in the case of the cancer data.
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3. METHODOLOGY

3.1 Feature Selection
As the years progress, the dimensionality of data keeps increasing in both the number of
instances as well as the number of features in various applications. This high-dimensionality
leads to problems such as scalability and learning performance of many machine learning
algorithms. For instance, high-dimensional data such as the TCGA ovarian cancer data with
17,814 genes can have a large number of irrelevant and redundant genes, which may
significantly reduce the performance of machine learning algorithms. As the dimensionality of a
dataset increases, there is an increasing difficulty in proving the result statistically significant due
to the sparsity of the meaningful data in the dataset in question. With an increase in
dimensionality also comes an increase in computational cost which is usually exponentially. To
overcome this problem we use feature selection methods to reduce the number of features in
consideration.
Feature selection is a very essential requirement when dealing with high-dimensional
data so that data overfitting is avoided and further analysis is possible. Feature selection
algorithms are divided into two categories which include the filter model and the wrapper model.
Using the filter model, certain features are selected based on general characteristics of the
training data without the use of any learning algorithm. On the other hand, the wrapper model
uses the performance of a predetermined learning algorithm to evaluate and select the features.
The wrapper model has a superior learning performance than the filter model since it selects
features which are more suited to the predetermined learning algorithm; however, it tends to be
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more computationally expensive than the filer model. So, the filter model is often preferred due
to its computational efficiency when dealing with a large number of features.
In this paper, the feature selection method that is applied to the TCGA ovarian cancer
data is a stepwise correlation-based selector (SCBS). The underlying assumption we make from
a biological perspective is that cancer phenotype is directly associated with gene expression. The
17,814 genes from our TCGA ovarian cancer data are fed into the stepwise correlation-based
selector (SCBS) and the selection process begins. We begin by computing the correlation
between the genes and survival time. At this step, we detect those genes which are significantly
correlated with survival time and these genes are selected to be a part of our subset. In the next
step, we select those genes which are correlated with the genes that were selected in the first
step. We continue in this manner of progressively selecting genes that correlate with the selected
genes until a subset with the desired number of genes is obtained. Using this stepwise
correlation-based selector, we select 603 genes from the total 17,814 genes. The SCBS algorithm
can be implemented as follows:

Step 1
Compute the
correlation
coefficients between
the current node 𝑋𝑖
and all the other
nodes.
Keep the 𝑘 highest
correlated nodes with
𝑋𝑖 for additional
filtering.

Step 2
Compute the 𝑝-value
of the correlation
coefficient for each of
the 𝑘 nodes selected in
step 1.
If the 𝑝-value is
significant under the
Benjamini-Hochberg
procedure with
𝐹𝐷𝑅 ≤ 0.05, the node
is selected.
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Step 3
Repeat step 1 and 2
until 𝑝 nodes are
selected.

The correlation coefficients are computed using Pearson’s correlation method. To perform the
hypothesis test, the correlations are transformed using Fisher’s z-transformation, which is a
function of 𝑟 whose sampling distribution of the transformed value is close to normal. Fisher’s ztransformation is given by

1
1+𝑟
𝑍 = ln (
)
2
1−𝑟

( 3.2.1)

where 𝑟 is the sample correlation, 𝑍 is the transformed value of 𝑟, and ln is the natural logarithm.
Using the fact that 𝑍 approximately follows a standard normal distribution, 𝑍~𝑁(0,1), we
compute the p-values of the correlation coefficients. Note that in the implementation of the
SCBS algorithm, 𝑘 is set to four. The value of 𝑘 is selected based on previous studies which
suggest that 𝑘 should be four, five, or six. A small value of 𝑘 fails to capture weakly connected
nodes and a large value of 𝑘 tends to capture more false positives.
When compared to single-round filtering methods, the stepwise correlation-based selector
appears to be more effective in selecting those with features, which are associated with the
phenotype-related pathways but are indirectly associated with the cancer phenotype. To better
understand this, let us consider the following scenario. Assume there is a casual relationship such
as 𝐴 → 𝐵 → 𝐶𝑎𝑛𝑐𝑒𝑟. Although there is a strong correlation between 𝐴 and 𝐵 or 𝐵 and cancer,
the correlation between 𝐴 and cancer could decay significantly to the extent of being
undetectable.
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3.2 Graphical Lasso
Recently, the estimation of the inverse covariance in a high-dimensional setting where
the number of features 𝑝 is greater than the number of observations 𝑛 has gained much interest.
Even more so, the estimation of a sparse inverse covariance matrix has gained more spotlight.
This is because it involves the estimation of the inverse covariance matrix which has some
elements equal to zero. For instance, in an 𝑛 × 𝑝 data matrix 𝑋 with independent rows which are
distributed 𝑁(0, Σ), a zero in an off-diagonal element of Σ −1 would be due to a pair of variables
which are conditionally independent. To this end, if we assume a multivariate Gaussian
distribution then we can estimate a graphical model for the data using the estimation of the
sparse inverse covariate matrix.
In the graphical model, each node represents a feature and the edge between the
corresponding pair of nodes represents the nonzero off-diagonal element in the inverse
covariance matrix. Usually, Σ −1 is estimated by maximizing the log-likelihood of the data. Using
the Gaussian model, we can represent the log-likelihood as

log det Σ −1 − 𝑡𝑟(SΣ −1 )

where 𝑆 =

𝑋𝑇𝑋
𝑛

( 3.2.2)

is the estimated covariance matrix of the data. Let Θ = Σ −1. Then we can

̂ = 𝑆 −1. Generally, this estimate does
denote the maximum likelihood estimate of (3.2.2 ) by Θ
not contain any elements equal to zero. In addition, having more features than observations in
our data, that is, 𝑝 ≫ 𝑛, will produce an 𝑆 which is singular so we would not be able to compute
the maximum likelihood estimate.
12

Yuan and Lin [46] proposed an alternative to this, which involves maximizing the
penalized log-likelihood over nonnegative definite matrices Θ, instead of simply maximizing the
log-likelihood. The penalized log-likelihood is

log det Θ − 𝑡𝑟(𝑆Θ) − 𝜆‖Θ‖1

( 3.2.3)

where 𝜆 is a nonnegative tuning parameter. This problem is referred to as the graphical lasso
(Friedman, Hastie, and Tibshirani [11]).
There are two main advantages of using a penalized log-likelihood rather than the simple
log-likelihood. First, regardless if 𝑆 is singular, the solution will always be positive definite for
̂ will be sparse because of the lassoall 𝜆 > 0. Second, for a sufficiently large 𝜆, the estimated Θ
type penalty, which has been applied to the elements of Θ (Tibshirani [41]).
In order for the solution to the graphical lasso problem to be block diagonal with blocks
𝐶1 , 𝐶2 , … , 𝐶𝐾 , that is, for a set of nodes to form a connected component in the graphical model, a
necessary and sufficient condition is required. The condition is that |𝑆𝑖𝑖′ | ≤ 𝜆 for all 𝑖 ∈ 𝐶𝑘 , 𝑖′ ∈
𝐶𝑘′ , 𝑘 ≠ 𝑘′. This condition was discovered by Mazumder and Hastie [26] and can be
implemented prior to solving equation (3.2.3) so that large computational gain is achieved.
The R package for graphical lasso with version glasso1.7 uses the above condition to
estimate a sparse inverse covariance matrix using a lasso (𝑙1 ) penalty. The general idea behind
the algorithm implemented in this package is that for a specified value of the tuning parameter, if
the solution to the graphical lasso problem will be block diagonal, then the graphical lasso
algorithm is applied to each block separately. Using a block diagonal screening decreases
computation time significantly.
13

The covariance matrix, 𝑆, which is a symmetric 𝑝 × 𝑝 matrix is computed from our 𝑛 × 𝑝
data matrix 𝑋. Note that 𝑛 is the number of samples at risk of death which is 296 and 𝑝 is the
number of genes which is 603. The glasso function is applied to the covariance matrix 𝑆 and the
value of lambda, the regularization parameter for lasso is set equal to 0.1. A smaller value of 𝜆 is
always preferred to a larger value of 𝜆. This is due to the fact a smaller value of 𝜆 yields less
sparse Θ which fits the data well while a larger value of 𝜆 yields a sparser Θ which fits the data
less well.
The output from the glasso function includes: 𝑤 which is the estimated covariance
matrix, 𝑤𝑖 which is the estimated inverse covariance matrix, 𝑙𝑜𝑔𝑙𝑖𝑘 which is the value of the
maximized log-likelihood penalty, 𝑑𝑒𝑙 which is the change in the parameter value at
convergence, 𝑛𝑖𝑡𝑒𝑟 which is the number of iterations of the outer loop used by the algorithm,
𝑎𝑝𝑝𝑟𝑜𝑥, and 𝑒𝑟𝑟𝑓𝑙𝑎𝑔.
Butts et al. [6] developed the network package in R, which provides a general framework
for encoding complex relational structures composed of a vertex set along with a combination of
edges. The tools in this package allow us to create, access, and modify network class objects
which facilitate the representation of more complex structures from adjacency matrices. In
addition, it also allows us to efficiently handle large sparse networks.
Let 𝐺 denote a network, a relational structure on a given vertex set (𝑉) and an edge, such
that 𝑇 is the “tail set” of the edge and 𝐻 is the corresponding “head set” belonging to the ordered
pair (𝑇, 𝐻) with the property that 𝑇, 𝐻 ⊆ 𝑉(𝐺). The cardinality of the vertex set and
corresponding edge set are denoted by |𝑉(𝐺)| = 𝑛 and |𝐸(𝐺)| = 𝑚, respectively. In an
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undirected network, the head and tail sets of an edge are interchangeable, meaning that 𝑖 is
adjacent to 𝑗 if there exists an edge such that 𝑖 ∈ 𝑇, 𝑗 ∈ 𝐻 or 𝑖 ∈ 𝐻, 𝑗 ∈ 𝑇.
Using the inverse covariance matrix 𝑤𝑖 which was previously estimated using the glasso
function, we construct our adjacency matrix. The network function uses the adjacency matrix to
create an undirected network object. The object is plotted and a two-dimensional plot of the
undirected network is obtained.

3.3 Cox proportional hazard model with sparse group lasso penalty
The advantage of using sparse group lasso over lasso and group lasso is that it generates a
solution, which is both between and within group sparsity. Using the SGL package in R, which
was developed by Simon et al. [35], we fit a cox proportional hazard model via a penalized
maximum likelihood, which is a combination of a lasso and group lasso regularization. This
package contains four functions, two of which we use; cvSGL and SGL. The cvSGL function is
used to fit and cross-validate a cox model via the penalized maximum likelihood.
The arguments specified in the function are: data, index, type, nlam, nfold, and alpha.
The argument ‘data’ is a list which consists of an 𝑛 × 𝑝 input matrix 𝑋, an 𝑛-vector time which
corresponds failure/censor times, and an 𝑛-vector status which indicates failure (1) or censoring
(0). In our case, 𝑋 is a 568 × 603 matrix with gene expression levels with 𝑛 being the total
number of samples, and 𝑝 being the number of genes selected using SCBS. The argument
‘index’ is a 𝑝-vector which indicates group membership of each covariate. To construct the index
vector, we use the estimated inverse covariance matrix 𝑤𝑖 generated using the glasso function
since this was used for the estimation of the undirected network in the network function. All
15

−1
genes belonging to the cluster (Σ𝑖𝑗
≠ 0) are assigned to group 1 and those genes not belonging
−1
to the cluster (Σ𝑖𝑗
= 0) are each assigned a different group number. Type corresponds to the

model type; in our case, the cox model. The argument ‘nlam’ corresponds to the number of
lambdas to use in the regularization path which we set equal 10 and ‘nfold’ corresponds to the
number of folds of the cross-validation loop which is set equal to 5. The mixing parameter, 𝛼,
determines how much weight should be given to either the lasso or group lasso regression. In
our case, we set the mixing parameter, alpha equal to 0.95 which indicates that more weight is
given to the lasso than the group lasso. Note that choosing a value of 𝛼 which is close to 1
eliminates any degeneracies and problematic behavior caused by extreme correlations.
The cvSGL function runs a total of (𝑛𝑓𝑜𝑙𝑑 + 1) times. In the first run, the sequence of
lambda is generated. The cross-validated error rate and its standard deviation are computed in the
consecutive runs. The output values of the cvSGL function include: lldiff which is an nlam
vector of cross-validated log-likelihoods, llSD which is an nlam vector of approximated standard
deviations of lldiff, lambdas which is a list of the values of lambda used in the regularization
path, type which is the response type, and fit which is a model fit object created.
The sparse group penalty model can be extended to other models. The two most common
cases in which this model is implemented include logistic regression and the cox model for
survival data. In a cox regression model, the data is a covariate matrix, 𝑋, which is divided into
sub-matrices based on the groups, an 𝑛-vector 𝑦 which contains failure censoring times, and an
𝑛-vector 𝛿 which indicates failure or censoring for each observation. Note that 𝛿𝑖 = 1 indicates
that observation 𝑖 failed and 𝛿𝑖 = 0 indicates the observation 𝑖 was censored. Under this model,
the sparse group lasso is expressed by
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𝑚

1
𝛽 = arg min [log (∑ ( ∑ exp(𝑥𝑗𝑇 𝛽) − 𝑥𝑖𝑇 𝛽 ))] + (1 − 𝛼)𝜆 ∑ √𝑝𝑙 ‖𝛽 (𝑙) ‖ + 𝛼𝜆‖𝛽‖1
𝛽 𝑛
𝑖∈𝐷

𝑗∈𝑅𝑖

( 3.3.1)

𝑙=1

where 𝐷 is the set of failure indices, and 𝑅𝑖 is the set of indices, 𝑗, such that we have 𝑦𝑗 ≥ 𝑦𝑖
which denotes those patients still at risk at failure time 𝑖.

3.4 Kaplan-Meier Curves
In 1958, Edward L. Kaplan and Paul Meier developed a way of dealing with incomplete
observations and as a result, Kaplan-Meier curves and estimates of survival data have become
useful in dealing with differing survival times such as times-to-event in which some of the
subjects do not continue in the study. Time-to-event can be defined as a clinical duration variable
for each subject in the study. It may begin at the point in time when the subject becomes a part of
a study or when the subject begins receiving treatement and ends when the subject reaches the
event of interest or is censored from the study.
Kaplan-Meier survival analysis requires three variables for each of the subjects in the
study. These variables include the survival time (time-to-death), their status at the end of the
study (event occurrence or censored), and the group they belong to. Censoring occurs when the
total survival time for a subject cannot be correctly determined due to reasons such as the subject
dropping out from the study or the subject survives until the end of the study (Rich et al. [30]).
The Kaplan-Meier estimate is the simplest way of estimating a population survival curve
from a sample as it allows us to compute the survival over time regardless of the difficulties
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associated with subjects or situations. In estimating the survival curve, we compute the
probabilities of the occurrence of an event at a certain point of time and multiply these
successive probabilities by any previously computed probabilities to get the final estimate. The
Kaplan-Meier estimator of the survival function at time 𝑡 is

𝑆(𝑡) = ∏
𝑡(𝑖) ≤𝑡

𝑛𝑖 − 𝑑𝑖
𝑛𝑖

( 3.4.1)

where 𝑛𝑖 denotes the number at risk of dying at 𝑡(𝑖) and 𝑑𝑖 denotes the observed number of
deaths. Note that 𝑆(𝑡) = 1 if 𝑡 < 𝑡(1) . The survival probability is calculated by dividing the
number of subjects surviving by the number of patients at risk. Subjects at risk do not include
subjects who have died, dropped out of the study, or have been censored (Goel et al. [18]).
The cox proportional hazard model is useful in identifying variables, which may be of
prognostic importance. In theory, the number of variables which can be included in the cox
model are infinite. For a regression model with 𝑘-variables, the hazard function is

ℎ(𝑡, 𝑥1 , 𝑥2 , … , 𝑥𝑘 , 𝛽) = ℎ0 (𝑡) exp(𝛽0 + 𝛽1 𝑥1 + 𝛽2 𝑥2 + ⋯ + 𝛽𝑘 𝑥𝑘 )

( 3.4.2)

where ℎ0 (𝑡) is the baseline hazard function, 𝛽0 is the intercept, and 𝛽1 , 𝛽2 , … , 𝛽𝑘 are the
corresponding regression coefficients estimated in the modelling process.
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We can express the above equation as a log-hazard function in the form

ln [

ℎ(𝑡, 𝑥1 , 𝑥2 , … , 𝑥𝑘 , 𝛽)
] = 𝛽0 + 𝛽1 𝑥1 + 𝛽2 𝑥2 + ⋯ + 𝛽𝑘 𝑥𝑘
ℎ0 (𝑡)

( 3.4.3)

Although it is possible to include an infinite number of variables in the model, there are
practical constraints in the estimation of the regression coefficients. For this reason, the number
of variables included in the model cannot be greater than the number of events available for the
analysis.
To calculate the confidence interval (CI), 𝑆(𝑡) is transformed using a scale which
approximately follows a Normal distribution. This is commonly achieved using a logarithmic
transformation of 𝑆(𝑡). Using this transformed scale, the endpoints of a 100(1 − 𝛼) percent
confidence interval for the log-log survival function are given by the expression

̂ {ln [− ln (𝑆(𝑡))]}
ln [− ln (𝑆(𝑡))] ± 𝑧1−𝛼/2 𝑆𝐸

( 3.4.5)

where 𝑧1−𝛼/2 is the upper 𝛼/2 percentile of the standard normal distribution.
Taking the antilog of the lower and upper values of the CI in (3.4.5) allows us to return to
the untransformed scale. The lower and upper endpoints of the confidence interval for the
survival function are, respectively

exp[− exp( 𝑐̂𝑢 )] and exp[− exp( 𝑐̂𝑙 )]
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( 3.4.6)

Note that since 𝑆(𝑡) always has values ranging from 0 to 1, the CI computed with (3.4.6) will
always be in the range of 0 to 1.
When interpreting K-M curves, we look for gaps in these curves in a horizontal or
vertical direction. A horizontal gap indicates that a particular group took longer to experience a
certain fraction of deaths. A vertical gap indicates that at a specific point in time, a particular
group had a greater fraction of subjects surviving. The Kaplan-Meier survival analysis is a
convenient method of estimating survival times as it allows us to use the information from
subjects who are censored up to the time when they are censored (Machin et al. [24]).
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4. RESULTS AND DISCUSSION

4.1 Results
Using the ‘data matrix’ tool available in TGCA data portal, the data was extracted. This
data set contains the expression values of 17,814 genes. Table 4.1.1 presents a summary of
TCGA ovarian cancer data, which includes the data types we incorporated in the analysis and the
number of available cases for each data type.

Data type
Platform
Cases
Gene expression
Agilent G4502A_07 583
Clinical information N/A
585
Table 4.1.1. Summary of TCGA ovarian cancer data.

Using the stepwise correlation-based selector (SCBS) approach for feature selection, a
subset of 603 genes was selected from the total 17,814 genes. The sparse inverse covariance
matrix was estimated using the blockwise coordinate descent algorithm for penalized maximum
likelihood estimation which is employed in the glasso package in R. The undirected network was
constructed using the network package in R. The predicted network contains 589 nodes within
the cluster and the remaining 14 nodes are not connected.
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Figure 4.1.1. Undirected network generated using the graphical lasso algorithm with a
regularization parameter 𝛌 = 𝟎. 𝟏.
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We applied the cox proportional hazard model with sparse group lasso penalty to fit a
survival model to our data. The 603 gene expression levels for all 568 samples along with the
clinical information for these samples were fed into the sparse group lasso (SGL) algorithm
which is implemented in R. The survival time is given in days and it is defined as the time
between diagnosis and death. The death risk (status) is treated as a binary variable which
represent failure as 1 and censoring as 0. The index for all 603 genes contains the group
membership of genes. The 589 genes which are in the same cluster are assigned to group 1 and
the remaining 14 genes which do not belong to the cluster are each assigned to a different group
from group 2 to group 15.
A cox proportional hazard model is fit to the data using 10 lambdas in the regularization
path and 5 folds for the cross-validation loop. Using the log-likelihoods along with the lambda
values used in the regularization path from the output, we construct a plot.

Number
1
2
3
4
5
6
7
8
9
10

Lambda
0.003507721
0.002514584
0.001802633
0.001292256
0.000926381
0.000664096
0.000476071
0.000341282
0.000244655
0.000175386

Log likelihood
2149.039
2220.560
2362.001
2613.528
3013.686
3694.887
4995.810
8315.698
14627.111
25431.210

Table 4.1.2. Lambda values with their corresponding log-likelihood computed by cv.SGL.
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Figure 4.1.2. Plot of the log-likelihoods against their corresponding lambda values.
A common method for selecting the tuning parameter 𝜆 is to use cross-validation to select
the optimal 𝜆 (Sun et al. [39]; Wasserman and Roeder [42]; Sofer et al. [37]). The problem with
using the cross-validation method is that it yields large number of false positives in the sparse
network problem (Fu and Zhou [14]). A method which has shown to be more effective in
indentifying the optimal 𝜆 is the “change point” method. The “change point” method uses the
change in the log likelihood for different values of 𝜆. Based on this method, the optimal 𝜆
corresponds to the change point at which increasing 𝜆 does not yield a significant decrease in the
log likelihood value. The optimal lambda selected is lambda 7 with a value of 𝜆=0.000476071.
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Using the optimal 𝜆 that was selected, we fit a cox proportional hazard model with a
combination of lasso and group lasso regularization. The input matrix, survival time, status and
index all remain the same as what was used in the cv.SGL function. The difference in using the
SGL function is that the optimal 𝜆, lambda 7, is used in fitting the cox model to the data. The
mixing parameter, 𝛼, is set equal to 0.95. The beta cofficients for all 603 genes were estimated
using the cox model in the SGL function. After fitting the regression model to the data, those
genes for which the null hypothesis (𝐻0 : 𝛽𝑖 = 0) is rejected, are kept in the model and are
termed prognostic. The remaining genes which are not statistically different from zero are
removed from the model and are not considered prognostic for the outcome.
The total number of genes with nonzero beta coefficients is 232 genes. Using the gene
expression level for these 232 genes along with their estimated beta coefficients, we will
compute the survival rate for all 568 samples. The survival estimates are computed by

𝑆𝑖 = 𝛽0 + 𝛽1 𝑔1𝑖 + 𝛽2 𝑔2𝑖 + ⋯ + 𝛽232 𝑔232𝑖

( 4.1.1)

where 𝛽1 , 𝛽2 , … , 𝛽232 are the corresponding regression coefficients estimated in the modelling
process and 𝑖 is the index for the sample where 𝑖 = 1, 2, … , 568.
After computing these survival estimates, we will sort these estimates in ascending order.
We evenly divide the survival estimates into 2 groups where group 1 includes the first 284
estimates and group 2 includes the remaining 284 estimates. Similarly, we divide the survival
estimates into 3 groups while sorted in ascending order. The survival package in R allows us to
construct survival curves from a fitted cox model using the survfit function. Kaplan-Meier curves
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will be plotted using the survival time and status for the 2 groups (low risk and high risk). The
procedure is also repeated for the case of 3 groups (low risk, medium risk, and high risk).

Figure 4.1.3. Kaplan-Meier curves with 95% confidence intervals for low and high-risk groups.
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Figure 4.1.4. Kaplan-Meier curves with 95% confidence intervals for low, medium, and highrisk groups.
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4.2 Discussion
The K-M estimates of the survival curves are given by the graph of 𝑆(𝑡) against time in
days in figures 4.1.3 and 4.1.4. 𝑆(𝑡) begins at 1, where all patients in the study are alive, since
𝑆(0) = 1 and then progressively decline towards 0 where all patients have died with time. Since
the estimated survival curve remains at a plateau between successive patient death times, the
graph of 𝑆(𝑡) is plotted as a step function. At each time of death, there is an instantaneous drop
to a new level. The graph only attains a value of 0 if the patient with the longest observed
survival time dies. In the event that the patient is still alive, the K-M curve has a plateau which
begins at the time of the last death and continues until the censored survival time of this longest
surviving patient. The censored survival times are marked on the curve with bold vertical lines
cutting the curve.
Since we are estimating the difference between 2 groups and 3 groups depending on the
potential risk, it is useful to calculate confidence intervals (CI) for the estimates. The survival
estimates were partitioned into 2 and 3 groups based on low risk and high risk and low risk,
medium risk, and high risk, respectively. The corresponding survival curves were estimated
using the samples that fall into these groups. As a measure of the reliability of the estimates at
key points along the K-M survival curves, we computed the 95% CI for 𝑆(𝑡) at time 𝑡.
The survival curves show a better outcome for low risk patients than the high risk
patients in figure 4.1.3. As expected, the survival curves indicate a gradient of survival
differences between the two groups. Since the K-M curves for the different risk groups are
adequately separated, these groups can be used for prognosis. It can be noted from figure 4.1.4
that even though there is a clear difference between low, medium, and high risk groups, the
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separation between the three groups is not as pronounced as that of figure 4.1.3. For instance, the
medium and high risk groups have ‘shrunk’ closer to each other while the low risk group appears
to have a relatively similar prognosis.
From the 232 genes which were termed prognostic for ovarian cancer survival, we found
10 of those genes which are directly related to cancer. Protein ubiquitination (CCNB1IP1) is
important for many cellular processes as it is able to regulate protein degradation and signal
mechanisms. Alterations of the ubiquitination mechanism have become evident in human
cancers. Levels of UB ligases have been found to be significantly correlated with relevant
prognostic factors as well as with the clinical outcome (Confalonieri et al. [7]). CDK5RAP2 is
necessary for spindle checkpoint function (Zhang et al. [51]). The expression of COL2A1 has
also shown useful in predicting tumor recurrence in high-grade serous ovarian cancer (Ganapathi
et al. [16]). COL8A1 in hepatocarcinoma cells has shown to be correlated with increased tumor
cell proliferation (Ma et al. [23]). Over-expression of EIF6 has shown to increase the motility
and invasiveness of cancer cells by controlling the expression of a critical subset of membranebound proteins (Pinzaglia et al. [28]). GATA6 promotes colon cancer cell invasion through the
regulation of urokinase plasminogen activator (uPA) gene expression. It contributes to colorectal
tumorigenesis and tumor invasion (Belaguli et al. [4]). Splice variants (SVs) of receptors for the
growth hormone-releasing hormone (GHRH) have been detected in several human cancers and
cancer cell lines. Antagonists of GHRH have shown to inhibit growth of various human cancers
(Garcia-Fernandez et al. [15]). The expression of interferon regulatory factor-1 (IRF-1) is a
nuclear transcription factor which mediates interferon and other cytokine effects. IRF-1 appears
to have antitumor activity in vitro and in vivo in cancer cells (Kim et al. [20]). The expression
NLRX1 acts as a potential tumor suppressor through the regulation of the TNF-α induced
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apoptosis (cell death) and metabolism in cancer cells (Singh et al. [36]). The expression level of
presenilin 1 (PSEN1) has shown to be negatively correlated with chemoresistance. A minor
interference of the RNA mediated repression in the PSEN1 gene has shown to suppress cell
apoptosis, the multi-chemoresistance of bladder cancer (Deng et al. [10]).

Gene
Symbol

Gene Name

Cyclin B1 Interacting
Protein 1 , E3 Ubiquitin
Protein Ligase
CDK5 Regulatory
CDK5RAP2 Subunit Associated
Protein 2
Collagen, Type II, Alpha
COL2A1
1
Collagen, Type VIII,
COL8A1
Alpha 1
Eukaryotic Translation
EIF6
Initiation Factor 6
GATA6
GATA Binding Protein 6
Growth Hormone
GHRH
Releasing Hormone
Interferon Regulatory
IRF1
Factor 1
NLRX1
NLR Family Member X1
PSEN1
Presenilin 1
CCNB1IP1

Resource
http://www.ncbi.nlm.nih.gov/pubmed/19543318

http://www.ncbi.nlm.nih.gov/pubmed/19282672
http://www.ncbi.nlm.nih.gov/pubmed/26311224
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3
501407
http://bmccancer.biomedcentral.com/articles/10.1
186/s12885-015-1106-3
http://www.ncbi.nlm.nih.gov/pubmed/21076612
http://www.ncbi.nlm.nih.gov/pubmed/12602901
http://www.nature.com/onc/journal/v23/n5/full/1
207023a.html
http://www.ncbi.nlm.nih.gov/pubmed/25639646
http://www.ncbi.nlm.nih.gov/pubmed/25542424

Table 4.2.1. Ten cancer-related genes, which were found to be prognostic for ovarian cancer
survival, based on the cox proportional hazard model with sparse group lasso penalty.

30

Gene Symbol
CCNB1IP1
CDK5RAP2
COL2A1
COL8A1

EIF6
GATA6
GHRH
IRF1
NLRX1

PSEN1

Function
Functions in progression of the cell cycle through G(2)/M
Potential regulator of CDK5 activity via its interaction with CDK5R1
Essential for the normal embryonic development of the skeleton, for linear
growth and for the ability of cartilage to resist compressive forces
Necessary for migration and proliferation of vascular smooth muscle cells
and thus, has a potential role in the maintenance of vessel wall integrity and
structure
Binds to the 60S ribosomal subunit and prevents its association with the 40S
ribosomal subunit to form the 80S initiation complex in the cytoplasm.
Transcriptional activator that regulates SEMA3C and PLXNA2
essential for normal expansion of the somatotrope lineage during pituitary
development
Plays roles in the immune response, regulating apoptosis, DNA damage and
tumor suppression
Participates in antiviral signaling. Acts as a negative regulator of MAVSmediated antiviral responses, through the inhibition of the virus-induced
RLH (RIG-like helicase)-MAVS interaction
Plays a role in intracellular signaling and gene expression or in linking
chromatin to the nuclear membrane

Table 4.2.1. Functions of the ten cancer-related genes, which were found to be prognostic for
ovarian cancer survival, based on the cox proportional hazard model with sparse group lasso
penalty.

Based on the presence of these ten cancer-related genes in our cox proportional hazard
model for cancer survival, we have shown that ovarian cancer shares common genes with other
cancer types due to the pathological similarity. These findings suggest that certain genes could
play essential and common roles across different cancer types.
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5. CONCLUSIONS

5.1 Summary
The stepwise correlation-based selector was used in selecting relevant genes for ovarian
cancer survival. Out of the 17,814 genes, a subset of 603 genes was selected using SCBS. These
603 genes were then used to estimate the sparse inverse covariance matrix through the graphical
lasso algorithm and an undirected network of these genes was constructed. Genes belonging to
the same cluster were assigned to the same group and genes outside of the cluster were each
assigned a different group number. A cox proportional hazard model with sparse group lasso
penalty was fit to our data. The model determined 232 genes which are prognostic in cancer
survival. Survival estimates were calculated using the gene expression levels and the estimated
beta coefficients for these 232 genes. Based on these estimates, we divided the samples into 2
and 3 groups based on low risk, medium risk, and high risk. The K-M curves for the different
risk groups were adequately separated which may suggest that these groups can be used for
prognosis. Of these 232 genes, many were reported to be associated with cancer initiation or
progression in the literature. Based on these findings it appears that certain genes share common
roles across different types of cancer.
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5.2 Future Work
In this paper, we considered gene expression levels as prognostic biomarkers in ovarian
cancer survival. Although the results presented here have demonstrated the effectiveness of
identifying biomarkers important in cancer survival, it could be further developed in a number of
ways. Future extensions to this research could include: incorporation of more genomic profiles,
use of Bayesian network modeling, extension of the graphical lasso model for nonparanormal
distribution, use of cross-validation to select an optimal value for the mixing parameter (𝛼), and
using a smaller value for the regularization parameter, 𝜆, along with community detection to
partition the network structure into more clusters.
Carcinogenesis involves multi-level dysregulations, which include genomics, DNA
methylomics, and transcriptomics (An et al. [1]). With recent advances in rapid high-throughput
genetic and genomic analysis, we are now able to identify a plethora of alterations which can
possibly serve as new cancer biomarkers. Each distinct data type such as copy number variations,
gene and microRNAs expression, CpG island methylation provides us with a different,
somewhat independent, and complementary view of the entire genome (Sokolova et al. [38]). To
understand a gene function, it is necessary to analyze more than one single type of data. For us to
be able to uncover the intricate underlying mechanisms, we must go beyond simply
understanding one molecular level of cancer.
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Data type
Platform
Cases
Gene expression
Agilent 244K 583 (8 organ-specific controls)
Somatic mutation
Agilent 415K 587 (8 organ-specific controls)
DNA methylation
Illumina 27K 592 (8 organ-specific controls)
Copy number variation Agilent 1M
587 (8 organ-specific controls)
Clinical information
N/A
585
Table 5.2.1. Summary of TCGA ovarian cancer data including data types, platform, and the
number of available cases.

Bayesian network (BN) is a probabilistic model consisting of a directed acyclic graph
(DAG) and an underlying joint probability distribution which uses the prior probability in the
prediction of dependent variables. With the use of Bayesian network, we are able to model a
multidimensional probability distribution in a sparse way while at the same time searching for
independency relations in the data. Compared to the undirected network model, directed
networks models such as the Bayesian network are more informative since we are able to
visualize the influences and relations of genes as well as describe hidden dependencies among
genes. Bayesian network is of great interest in bioinformatics since the probabilistic inference
provides a passage for clinical decision making through the intuitive encapsulation of causal
links, which exist between diagnostic and prognostic factors (Gevaert et al. [17]; Sesen et al.
[32]).
The Gaussian graphical model is the standard parametric model used for continuous data;
however, its distributional assumptions are generally unrealistic. For real-valued data in highdimensional situations, the estimation of sparse undirected graphs relies heavily of the
assumption of normality. Assuming normality is not always realistic, especially in a practical
setting. Both the nonparanormal and Gaussian graphical models can be used in graph estimation
and construction; however, they yield different graphs over a wide range of regularization
parameters, which suggests the possibility of having different biological conclusions (Lafferty et
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al. [21]). Fitting a high-dimensional nonparanormal model can also be achieved using the
graphical lasso approach and is no more computationally difficult than estimating a multivariate
Gaussian model.
Cross-validation is often performed to aid in model selection through the choice of an
optimal value of a penalty parameter. To select the optimal parameter value, a 10-fold crossvalidation (CV) is commonly used. The optimal parameter value is that value for which the 10fold cross-validated penalized (partial) log-likelihood deviance of the model is minimal (Sill et
al. [33]). In this research, the change point method was used to select the optimal value of the
regularization parameter, 𝜆; however, the mixing parameter 𝛼 was set to 0.95. Since we want to
achieve both sparsity between and within groups, using cross-validation to select an optimal
value of the mixing parameter 𝛼 will be more useful (Ritter [31]).
Community structure is the division of networks into communities (clusters), which are
densely connected among their members, and sparsely connected with the rest of the network
(Pizzuti [29]). It is an interesting property to investigate as it can reveal abundant hidden
information about complex networks, which cannot be not easily detected by simple observation
(Liu et al. [22]). One of the main problems in network and data sciences is community detection
(Abbe [1]). Detecting communities within a network can provide useful insights on the general
structure of the network so that we may further understand specific gene functions in these
complex biological networks. Common algorithms used for community detection include
Infomap, LPA, Fastgreedy and Walktrap. In this research, using a smaller value for the
regularization parameter, 𝜆, would yield a network with more clusters. We could then use a
community detection algorithm to detect communities within the undirected network based on
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similar characteristics and gene functions. This would allow us to have more groups when fitting
a cox proportional hazard model with a sparse group lasso penalty.
There is still a lot more work to be done before we can fully understand the prognostic
biomarkers in ovarian cancer survival. Employing different network models, relaxing the
normality assumption, using cross-validation to select an optimal value for the mixing parameter
(𝛼), as well as using a smaller value for the regularization parameter, 𝜆, to partition the network
structure into more clusters, along with community detection in the analysis of different genomic
profiles could potentially lead to the identification of new biomarkers.

36

REFERENCES
1 Abbe, E. (2016). Community detection and the stochastic block model.
2 An, N., Yang, X., Cheng, S., Wang, G., & Zhang, K. (2015). Developmental genes
significantly afflicted by aberrant promoter methylation and somatic mutation predict
overall survival of late-stage colorectal cancer. Scientific reports, 5.
3 Banerjee, O., El Ghaoui, L., & d'Aspremont, A. (2008). Model selection through sparse
maximum likelihood estimation for multivariate gaussian or binary data. The Journal of
Machine Learning Research, 9, 485-516.
4 Belaguli, N. S., Aftab, M., Rigi, M., Zhang, M., Albo, D., & Berger, D. H. (2010).
GATA6 promotes colon cancer cell invasion by regulating urokinase plasminogen
activator gene expression. Neoplasia, 12(11), 856-IN1.
5 Butts, C. T. (2008). network: a Package for Managing Relational Data in R. Journal of
Statistical Software, 24(2), 1-36.
6 Butts, C. T. (2015). network: Classes for Relational Data. R package version 1.12.0.
http://CRAN.R-project.org/package=network
7 Confalonieri, S., Quarto, M., Goisis, G., Nuciforo, P., Donzelli, M., Jodice, G., & Di
Fiore, P. P. (2009). Alterations of ubiquitin ligases in human cancer and their association
with the natural history of the tumor. Oncogene, 28(33), 2959-2968.
8 Cancer Genome Atlas Research Network. (2011). Integrated genomic analyses of ovarian
carcinoma. Nature, 474(7353), 609-615.
9 Chen, L., Xuan, J., Gu, J., Wang, Y., Zhang, Z., WANG, T. L., & SHIH, I. M. (2012).
Integrative network analysis to identify aberrant pathway networks in ovarian cancer. In
Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing (p. 31). NIH
Public Access.
10 Deng, H., Lv, L., Li, Y., Zhang, C., Meng, F., Pu, Y., & Zhang, D. (2015). The miR193a-3p regulated PSEN1 gene suppresses the multi-chemoresistance of bladder cancer.
Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 1852(3), 520-528.
11 Friedman, J., Hastie, T., & Tibshirani, R. (2008). Sparse inverse covariance estimation
with the graphical lasso. Biostatistics, 9(3), 432-441.
12 Friedman, J., Hastie, T., & Tibshirani, R. (2010). A note on the group lasso and a sparse
group lasso. arXiv preprint arXiv:1001.0736.
37

13 Friedman, J., Hastie, T., & Tibshirani, R. (2014). glasso: Graphical lasso- estimation of
Gaussian graphical models. R package version 1.8. http://CRAN.Rproject.org/package=glasso
14 Fu, F., & Zhou, Q. (2013). Learning sparse causal Gaussian networks with experimental
intervention: regularization and coordinate descent. Journal of the American Statistical
Association, 108(501), 288-300.
15 Garcia-Fernandez, M. O., Schally, A. V., Varga, J. L., Groot, K., & Busto, R. (2003). The
expression of growth hormone-releasing hormone (GHRH) and its receptor splice
variants in human breast cancer lines; the evaluation of signaling mechanisms in the
stimulation of cell proliferation. Breast cancer research and treatment, 77(1), 15-26.
16 Ganapathi, M. K., Jones, W. D., Sehouli, J., Michener, C. M., Braicu, I. E., Norris, E. J.,
& Ganapathi, R. N. (2016). Expression profile of COL2A1 and the pseudogene
SLC6A10P predicts tumor recurrence in high‐grade serous ovarian cancer. International
Journal of Cancer, 138(3), 679-688.
17 Gevaert, O., De Smet, F., Timmerman, D., Moreau, Y., & De Moor, B. (2006).
Predicting the prognosis of breast cancer by integrating clinical and microarray data with
Bayesian networks. Bioinformatics, 22(14), e184-e190.
18 Goel, M., Khanna, P., & Kishore, J. (2010). Understanding survival analysis: KaplanMeier estimate. International journal of Ayurveda research, 1(4), 274.
19 Hira, Z. M., & Gillies, D. F. (2015). A Review of Feature Selection and Feature
Extraction Methods Applied on Microarray Data. Advances in bioinformatics, 2015.
20 Kim, P. K., Armstrong, M., Liu, Y., Yan, P., Bucher, B., Zuckerbraun, B. S., & Yim, J.
H. (2004). IRF-1 expression induces apoptosis and inhibits tumor growth in mouse
mammary cancer cells in vitro and in vivo. Oncogene, 23(5), 1125-1135.
21 Lafferty, J., Liu, H., & Wasserman, L. (2012). Sparse nonparametric graphical models.
Statistical Science, 27(4), 519-537.
22 Liu, W., Pellegrini, M., & Wang, X. (2014). Detecting communities based on network
topology. Scientific reports, 4.
23 Ma, Z. H., Ma, J. H., Jia, L., & Zhao, Y. F. (2012). Effect of enhanced expression of
COL8A1 on lymphatic metastasis of hepatocellular carcinoma in mice. Experimental and
therapeutic medicine, 4(4), 621-626.
24 Machin, D., Cheung, Y. B., & Parmar, M. (2006). Survival analysis: a practical
approach. John Wiley & Sons.
38

25 Mazumder, R., & Hastie, T. (2012). Exact covariance thresholding into connected
components for large-scale graphical lasso. The Journal of Machine Learning Research,
13(1), 781-794.
26 Mazumder, R., & Hastie, T. (2012). The graphical lasso: New insights and alternatives.
Electronic journal of statistics, 6, 2125.
27 Meinshausen, N., & Bühlmann, P. (2006). High-dimensional graphs and variable
selection with the lasso. The annals of statistics, 1436-1462.
28 Pinzaglia, M., Montaldo, C., Polinari, D., Simone, M., La Teana, A., Tripodi, M., ... &
Benelli, D. (2015). eIF6 over-expression increases the motility and invasiveness of cancer
cells by modulating the expression of a critical subset of membrane-bound proteins. BMC
cancer, 15(1), 1.
29 Pizzuti, C. (2008). Ga-net: A genetic algorithm for community detection in social
networks. In Parallel Problem Solving from Nature–PPSN X (pp. 1081-1090). Springer
Berlin Heidelberg.
30 Rich, J. T., Neely, J. G., Paniello, R. C., Voelker, C. C., Nussenbaum, B., & Wang, E. W.
(2010). A practical guide to understanding Kaplan-Meier curves. Otolaryngology-Head
and Neck Surgery, 143(3), 331-336.
31 Ritter, S. J. (2013). Software for prediction and estimation with applications to highdimensional genomic and epidemiologic data (Doctoral dissertation, University of
California, Berkeley).
32 Sesen, M. B., Nicholson, A. E., Banares-Alcantara, R., Kadir, T., & Brady, M. (2013).
Bayesian networks for clinical decision support in lung cancer care. PloS one, 8(12),
e82349.
33 Sill, M., Hielscher, T., Becker, N., & Zucknick, M. (2014). c060: Extended inference
with lasso and elastic-net regularized Cox and generalized linear models. Journal of
Statistical Software, 62(5), 1-22.
34 Simon, N., Friedman, J., Hastie, T., & Tibshirani, R. (2013). A sparse-group lasso.
Journal of Computational and Graphical Statistics, 22(2), 231-245.
35 Simon, N., Friedman, J., Hastie, T., & Tibshirani, R. (2013). SGL: Fit a GLM (or cox
model) with a combination of lasso and group lasso regularization. R package version
1.1. http://CRAN.R-project.org/package=SGL
36 Singh, K., Poteryakhina, A., Zheltukhin, A., Bhatelia, K., Prajapati, P., Sripada, L., &
Singh, R. (2015). NLRX1 acts as tumor suppressor by regulating TNF-α induced
39

apoptosis and metabolism in cancer cells. Biochimica et Biophysica Acta (BBA)Molecular Cell Research, 1853(5), 1073-1086.
37 Sofer, T., Dicker, L., & Lin, X. (2012). Variable selection for high-dimensional
multivariate outcomes. Statistica Sinica, 22(4). 1633-54
38 Sokolova, V., Crippa, E., & Gariboldi, M. (2016). Integration of genome scale data for
identifying new players in colorectal cancer. World J Gastroenterol, 22(2), 534-545.
39 Sun, W., Wang, J., & Fang, Y. (2013). Consistent selection of tuning parameters via
variable selection stability. The Journal of Machine Learning Research, 14(1), 34193440.
40 Therneau, T. (2014). A Package for Survival Analysis in S. survival: Survival Analysis.
R package version 2.37-7. http://cran.r-project.org/web/packages/survival
41 Tibshirani, R. (1996). Regression shrinkage and selection via the lasso. Journal of the
Royal Statistical Society. Series B (Methodological), 267-288.
42 Wasserman, L., & Roeder, K. (2009). High dimensional variable selection. Annals of
statistics, 37(5A), 2178.
43 Witten, D. M., Friedman, J. H., & Simon, N. (2011). New insights and faster
computations for the graphical lasso. Journal of Computational and Graphical Statistics,
20(4), 892-900.
44 Ye, J., & Liu, J. (2012). Sparse methods for biomedical data. ACM SIGKDD
Explorations Newsletter, 14(1), 4-15.
45 Yu, L., & Liu, H. (2003, August). Feature selection for high-dimensional data: A fast
correlation-based filter solution. In ICML (Vol. 3, pp. 856-863).
46 Yuan, M., & Lin, Y. (2007). Model selection and estimation in the Gaussian graphical
model. Biometrika, 94(1), 19-35.
47 Zhang, Q. (2015). Learning Sparse Bayesian Network with Mixed Variables and its
Application to Cancer Systems Biology (Doctoral dissertation, NORTHWESTERN
UNIVERSITY).
48 Zhang, Q., Burdette, J. E., & Wang, J. P. (2014). Integrative network analysis of TCGA
data for ovarian cancer. BMC systems biology, 8(1), 1.
49 Zhang, Q., & Wang, J. P. (2015). A Bayesian network approach for modeling mixed
features in TCGA ovarian cancer data. bioRxiv, 033332.
40

50 Zhang, S., Lu, Z., Unruh, A. K., Ivan, C., Baggerly, K. A., Calin, G. A., ... & Le, X. F.
(2015). Clinically relevant microRNAs in ovarian cancer. Molecular Cancer Research,
13(3), 393-401.
51 Zhang, X., Liu, D., Lv, S., Wang, H., Zhong, X., Liu, B., & Xu, X. (2009). CDK5RAP2
is required for spindle checkpoint function. Cell cycle, 8(8), 1206-1216.

41

